the aid library

Tatsächliche und voraussichtliche Entwicklung der genuinen ODA-Leistungen Deutschlands insgesamt und für den Gesundheitsbereich

Tilman Rüppel, Joachim Rüppel medmissio (2024) CC

Die Grafik zur deutschen Entwicklungszusammenarbeit zeigt die Entwicklung der finanziellen Mittel Deutschlands im Zeitraum von 2014 bis 2024. Die absoluten Summen werden als Balken und in Eurobeträgen in Millionen dargestellt, während die Kurvenlinien die entsprechenden Prozentwerte im Verhältnis ... more

Argumentaire d'Investissement - Huitième reconstitution des ressources 2025

Le Fonds mondial (2025) CC

Pour atteindre les objectifs de sa stratégie et se rapprocher de la cible de l’ODD 3 liée aux trois maladies à l’horizon 2030, le Fonds mondial doit réunir 18 milliards de dollars US pour sa huitième reconstitution des ressources. Cette somme est le minimum requis pour faire progresser ... more

Investment Case - Achte Wiederauffüllung 2025 - Kurzüberblick

Der Globale Fonds (2025) CC

Damit wir die Meilensteine der Strategie des Globalen Fonds für 2028 einhalten können und SDG 3 für uns weiter erreichbar bleibt, benötigen wir 18 Milliarden US-Dollar, um die nächste dreijährige Förderperiode des Globalen Fonds finanzieren zu können.

Argumentos a Favor de la Inversión - Octava Reposición de Recursos 2025 - Resumen ejecutivo

El Fondo Mundial (2025) CC

Si queremos cumplir los hitos de la Estrategia del Fondo Mundial para 2028 y mantener a nuestro alcance la meta del ODS 3, necesitamos recaudar 18.000 millones USD para financiar el próximo ciclo de subvenciones trienal del Fondo Mundial.

Argumentaire d'Investissement - Huitième reconstitution des ressources 2025 - Résumé

Le Fonds mondial (2025) CC

Pour franchir toutes les étapes de la stratégie du Fonds mondial jusqu’en 2028 et nous assurer que la cible de l'ODD 3 reste à notre portée, nous devons mobiliser 18 milliards de dollars US pour notre prochain cycle triennal de subvention.

Investment Case - Auf einen Blick - Achte Wiederauffüllung 2025

Der Globale Fonds (2025) CC

Dies ist ein entscheidender Moment bei der Bekämpfung von HIV, Tuberkulose (TB) und Malaria. Für unsere achte Wiederauffüllung benötigt der Globale Fonds 18 Milliarden US-Dollar, um 23 Millionen Menschenleben zu retten, die Sterberate der drei Krankheiten um 64 % zu senken und am Aufbau einer We ... more

Resumen de los argumentos a favor de la inversión - Octava Reposición de Recursos 2025

El Fondo Mundial (2025) CC

Estamos en un momento decisivo de la lucha contra el VIH, la tuberculosis y la malaria. El Fondo Mundial necesita recaudar 18.000 millones USD en la Octava Reposición de Recursos para salvar 23 millones de vidas, reducir en un 64% la tasa de mortalidad de las tres enfermedades, y ayudar a construir ... more

Argumentaire d'Investissement - Survol - Huitième reconstitution des ressources 2025

Le Fonds mondial (2025) CC

Nous sommes à un moment crucial de la lutte contre le VIH, la tuberculose et le paludisme. Pour sa huitième reconstitution des ressources, le Fonds mondial a besoin de 18 milliards de dollars US pour sauver 23 millions de vies, réduire le taux de mortalité des trois maladies de 64 % et bâtir un ... more

Global Fund Launches Private Sector Investment Opportunity Ahead of Critical Eighth Replenishment

The Global Fund The Global Fund (2025) CC

Private sector engagement opens pathways for a game-changing US$2 billion investment opportunity in the fight against HIV, tuberculosis and malaria.

Chinese health funding in Africa: The untold story

Dolan C.B., Malik A.A., Zhang S., et al. PLOS Global Public Health (2023) CC

The motivations behind China’s allocation of health aid to Africa remain complex due to limited information on the details of health aid project activities. Insufficient knowledge about the purpose of China’s health aid hinders our understanding of China’s comprehensive role in supporting Afri ... more

Ambitions and realities: Are Global Fund investments designed to achieve resilient and sustainable systems for health?

Salisbury N., Nawaz S., Abenaitwe J., et al. PLOS Global Public Health (2024) CC

Strengthening resilient and sustainable systems for health (RSSH) is central to the Global Fund’s strategy, however questions persist about the Global Fund’s role in the health systems strengthening space, and the extent to which investments are designed to achieve strengthening objectives, or j ... more

Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis

Haakenstad A., Bintz C., Knight M., et al. Lancet Global Health (2023) CC

The COVID-19 pandemic disrupted health systems in 2020, but it is unclear how financial hardship due to out-of-pocket (OOP) health-care costs was affected. We analysed catastrophic health expenditure (CHE) in 2020 in five countries with available household expenditure data: Belarus, Mexico, Peru, R ... more

Comparing priority received by global health issues: a measurement framework applied to tuberculosis, malaria, diarrhoeal diseases and dengue fever

Parashar R., Nanda S., Smith S.L., et al. BMJ Global Health (2024) CC

The relative priority received by issues in global health agendas is subjected to impressionistic claims in the absence of objective methods of assessment of priority. To build an approach for conducting structured assessments of comparative priority health issues receive, we expand the public ... more

Germany’s role in global health at a critical juncture

Franz C., Holzscheiter A., Kickbusch I., et al. Lancet (2024) CC

When we presented our analysis of Germany’s role in global health in 2017 at an event in Berlin, Richard Horton, the Editor-in-Chief of The Lancet, asked only half-jokingly whether we could expect Germany to finally shrug off the habitus of the “reluctant leader” and “step up”. Back t ... more

How feasible is it to mobilize $31 billion a year for pandemic preparedness and response? An economic growth modelling analysis

Shahid M., Schäferhoff M., Brown G., et al. Globalization and Health (2024) CC

Covid-19 has reinforced health and economic cases for investing in pandemic preparedness and response (PPR). The World Bank and World Health Organization (WHO) propose that low- and middle-income governments and donor countries should invest $31.1 billion each year for PPR. We analyse, based on the ... more

What next for UK development assistance under the next government?

Buse K., McKee M. British Medical Journal (BMJ) (2024) CC

The UK could regain its leadershipin the provision of development assistance for healthunder the next government. But this doesn’t seem likely if the party manifestos are any guide.

Official Development Assistance (ODA) mit Fokus auf Gesundheit und Deutschland

Tilman Rüppel and Joachim Rüppel medmissio (2025) CC

Dieses Dokument stellt aktuelle Ergebnisse zum Thema Official Development Assistance (ODA) mit Fokus auf Gesundheit und Deutschland zur Verfügung.

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul ... d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

Folgen der US-Kürzungen und der Auflösung von USAID: Eine Analyse und Handlungsempfehlungen für Akteure in der Entwicklungszusammenarbeit

Liebau L., Rüppel T., Schottmayer K. medmissio (2025) CC

Dieses Dokument bietet eine Problemanalyse der US-Kürzungen im Bereich globale Gesundheit und leitet daraus konkrete Handlungsempfehlungen für medizinische Akteure ab. Im Fokus steht die Analyse der direkten Auswirkungen auf die gesundheitsspezifische Entwicklungszusammenarbeit.